ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Glaucocalyxin A attenuates carbon tetrachloride-induced liver fibrosis and improves the associated gut microbiota imbalance

Qu, Ru; Zhang, Wang; Ma, Zhuang; Ma, Qianwen; Chen, Mingju; Lan, Tian; Zhou, Lin; Hu, Xuguang*广东药学院; 1
Chemical Biology and Drug Design2023-7DOI: 10.1111/cbdd.14241
9阅读
引用收藏
分享

摘要

Liver fibrosis refers to the pathophysiological process of dysplasia on the connective tissue of the liver, caused by a variety of pathogenic factors. Glaucocalyxin A (GLA) has anticoagulation, antibacterial, anti-inflammation, antioxidant and antitumour properties. However, whether GLA ameliorates liver fibrosis or not is still unclear. In this study, a liver fibrosis model was established using male C57BL/6 mice. The mice were treated with 5 and 10 mg/kg GLA via intraperitoneal injection, respectively. The ones that were treated with 5 mg/kg OCA were used as the positive control group. The levels of liver function, liver fibrosis biomarkers and liver pathological changes were then evaluated. We also explored the effects of GLA on inflammatory response and liver cell apoptosis. In addition, we investigated the gut microbiota mechanisms of GLA on liver fibrosis. The results from this study that GLA could significantly decrease the level of liver AST, ALT, TBA) and liver fibrosis (HA, LN, PC-III, IV-C). On the other hand, a significant decrease in inflammation levels (IL-1b, TNF-a) were also noted. GLA also improves CCl4-induced pathological liver injuries and collagen deposition, in addition to decreasing apoptosis levels. In addition, an increase in the ratio of Bacteroidetes and Firmicutes in liver disease was also observed. GLA also improves the gut microbiota. In conclusion, GLA attenuates CCl4-induced liver fibrosis and improves the associated gut microbiota imbalance.

学科与关键词

关键词
carbon tetrachlorideglaucocalyxin Agut microbiotainflammationliver fibrosis
相关
加载中…
  • Gut microbial dysbiosis is associated with metabolism and immune factors in liver fibrosis mice
    Zhao, Bingbing; Jin, Ye; Shi, Meixin; Yu, Ligen; Li, Guopeng; Cai, Wenjie; Lu, Zhaoyang; Wei, Can*International Journal of Biological Macromolecules, 2024, 258: 129052.
  • Aloin Attenuates Oxidative Stress, Inflammation, and CCl4-Induced Liver Fibrosis in Mice: Possible Role of TGF-β/Smad Signaling
    Bai, Junjie; Qian, Baolin; Cai, Tianying; Chen, Yifan; Li, Tongxi; Cheng, Yonglang; Wu, Ziming; Liu, Chen; Ye, Mingxin*; Du, Yichao*; Fu, Wenguang*Journal of Agricultural and Food Chemistry, 2023, 71(49): 19475-19487.
  • Design of a highly potent GLP-1R and GCGR dual-agonist for recovering hepatic fibrosis
    Song, Nazi; Xu, Hongjiao; Liu, Jiahua; Zhao, Qian; Chen, Hui; Yan, Zhibin; Yang, Runling; Luo, Zhiteng; Liu, Qi; Ouyang, Jianmei; Wu, Shuohan; Luo, Suijia; Ye, Shuyin; Lin, Runfeng; Sun, Xi; Xie, Junqiu; Lan, Tian; Wu, Zhongdao*; Wang, Rui*; Jiang, Xianxing*Acta Pharmaceutica Sinica B, 2022, 12(5): 2443-2461.被引 9
查看全部 →

发表信息

论文状态
公开发表
期刊
Chemical Biology and Drug Design
发表日期
2023-07
卷期
第 102 卷, 第 1 期
页码
51-64
DOI
10.1111/cbdd.14241
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81673620, 81870420, 82070590]

作者

  • Q

    Qu, Ru (第一作者)

    1 · guangdong pharmaceut univ

  • Z

    Zhang, Wang

    1 · guangdong pharmaceut univ

查看全部 8 位作者收起作者
  • M

    Ma, Zhuang

    1 · guangdong pharmaceut univ

  • M

    Ma, Qianwen

    1 · guangdong pharmaceut univ

  • C

    Chen, Mingju

    1 · guangdong pharmaceut univ

  • L

    Lan, Tian

    guangdong pharmaceut univ

  • Z

    Zhou, Lin

    guangdong pharmaceut univ

  • H

    Hu, Xuguang (通讯)

    guangdong pharmaceut univ · 1

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417